LORILEE PERRY: Open Payments
NPI 1083924906 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,365 in 54 payments from 15 companies in 2025. Trend: 2023 $68 · 2024 $603 · 2025 $1,365
Food & beverage: $1,365
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $275 |
| ABBVIE INC. | 14 | $183 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $181 |
| Lilly USA, LLC | 9 | $142 |
| Eisai Inc. | 1 | $125 |
| Novo Nordisk Inc | 6 | $125 |
| Exact Sciences Corporation | 3 | $86 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $65 |
| PFIZER INC. | 2 | $49 |
| Krystal Biotech Inc | 1 | $27 |
Products named: BREZTRI, JARDIANCE, Leqembi, MOUNJARO, Ozempic, The Cologuard Plus Collection Kit, UBRELVY, XIFAXAN.
Industry payments across CA — which companies pay providers there.
